1002 results about "Formamides" patented technology

The invention relates to the technical field of cable materials, in particular to a flame-retardant efficient cross-linked polyolefin cable body and a preparation method thereof. The cable body comprises a polyolefin matrix, 2, 4-dihydroxy-6-methyl benzamide, an intumescent flame retardant, dicumyl peroxide, an antioxidant, a light stabilizer and a lubricant, wherein the polyolefin matrix is subjected to synergistic modification by phosphorus-nitrogen heterocyclic silane-plasma. The preparation method of the polyolefin matrix synergistically modified by phosphorus-nitrogen heterocyclic silane-plasma comprises the following steps: performing grafting reaction on polyolefin resin and phosphorus-nitrogen heterocyclic silane under the action of an initiator, and performing plasma surface treatment to endow the material with dual active sites. The preparation method comprises the following steps: melting and granulating a polyolefin matrix subjected to phosphorus-nitrogen heterocyclic silane-plasma synergistic modification, small organic molecules and auxiliaries, and performing extrusion molding under a crosslinking condition to obtain a cable body. The material disclosed by the invention has comprehensive advantages in flame-retardant efficiency, crosslinking degree and mechanical property, and is suitable for manufacturing high-safety power cables.

Disclosed is a pharmaceutical composition for the treatment of tumors, the pharmaceutical composition comprising (6S, 9aS)-N-benzyl-8-({6-[3-(4-ethylpiperazin-1-yl) azetidin-1-yl] pyridin-2-yl} methyl)-6-(2-fluoro-4-hydroxybenzyl)-4, 7-dioxo-2-(propyl-2-en-1-yl) hexahydro-2H-pyrazino [2, 1-c] [1, 2, 3] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [ The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof and administered in combination with a MEK inhibitor.

The invention relates to the technical field of environmental protection, and discloses a method for degrading formamide organic wastewater and recycling key metals of a retired lithium ion battery. The method comprises the following steps: S1, obtaining the positive electrode material of the retired lithium ion battery, mixing the positive electrode material with formamide organic wastewater, and carrying out hydrothermal reaction to obtain a leachate; s2, adjusting the pH value of the leachate to 6-14, and carrying out a transition metal precipitation reaction to obtain a transition metal hydroxide precursor and a lithium-rich filtrate; and S3, adding a sodium carbonate solution into the lithium-rich filtrate, carrying out a precipitation reaction, and collecting lithium carbonate. The formamide organic wastewater serves as an endogenous reducing agent, deep degradation of the formamide organic wastewater is achieved under the hydrothermal condition, efficient leaching of key metal in the retired lithium ion battery is achieved, and waste is treated with waste; the formamide degradation efficiency can reach 90% or above, and the defects that an existing formamide wastewater treatment method is high in energy consumption, large in reagent consumption, high in cost, low in degradation efficiency and large in environmental treatment pressure are overcome.

The present invention relates to a process for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide of formula (I) and to the preparation and use of crystalline modification I of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide of formula (I).

The invention belongs to the technical field of medicinal chemistry, and particularly relates to a 3-sulfamoyl benzamide compound as well as a preparation method and application thereof. The 3-sulfamoyl benzamide compound has a structure as shown in a formula I. In the formula I, X is chlorine or trifluoromethyl; r1 and R2 are independently C1-4 alkyl or R1, R2 and N atoms connected with R1 and R2 jointly form a heterocyclic group, and the heterocyclic group is a substituted or unsubstituted five-membered or six-membered heterocyclic group; and when the heterocyclic group is a substituted heterocyclic group, the substituent group in the substituted heterocyclic group is one or more of C1-4 alkyl, phenyl and acetyl. The 3-sulfamoyl benzamide compound disclosed by the invention has a remarkable proliferation inhibition effect on HCT116 colon cancer cells, HeLa human cervical cancer cells, MDA-MB-231 human breast cancer cells and A375 human malignant melanoma cells.

The present disclosure provides, in part, five-membered heteroarylcarboxamide compounds useful for disrupting HBV core protein assembly, and pharmaceutical compositions thereof, and methods for treating hepatitis B (HBV) infection. In another aspect, the present disclosure provides a method of treating HBV infection in a subject in need thereof, the method comprising administering to the subject a pharmaceutical composition comprising a therapeutically effective amount of a compound of Formula I, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient.

The invention relates to preparation of a crystalline allyl covalent organic framework material and application research of the crystalline allyl covalent organic framework material in benzamide cyclization green photocatalytic conversion. The SF-COF material is prepared by adopting a step-by-step synthesis method. The preparation method comprises the following steps: synthesizing a COF precursor by taking 1, 3-benzenetricarboxaldehyde and p-aminophenylacetonitrile as raw materials, and preparing the allylation covalent organic framework material with the electronic push-pull effect from the COF precursor and 5, 5 ', 5'-(benzene-1, 3, 5-triyl) tri (thiophene-2-formaldehyde) through a solvothermal method. The material is applied to the field of photocatalytic organic conversion, and benzamide cyclization and conversion of derivatives of benzamide are achieved under irradiation of a blue light LED. The prepared SF-COF has the advantages of efficient charge separation and electron conduction performance, good structural stability and chemical stability and the like. And a catalyzed organic reaction substrate has the advantages of wide universality range, good cycle stability and the like, and shows excellent photocatalytic conversion capability.

The invention belongs to the technical field of drug development, and particularly relates to application of (E)-N-benzyl-2-((5-(thiophenyl) furan-2-yl) methylene) hydrazine-1-thioformamide in preparation of drugs for treating nervous system diseases. The invention aims to provide a medicine which has small toxic and side effects and can target SLC11A2 to treat or improve nerve cell injury. According to the technical scheme, the invention relates to application of (E)-N-benzyl-2-((5-(thiophenyl) furan-2-yl) methylene) hydrazine-1-thioformamide in preparation of a medicine for treating nervous system diseases, in particular to application of (E)-N-benzyl-2-((5-(thiophenyl) furan-2-yl) methylene) hydrazine-1-thioformamide. It is proved that the compound (E)-N-benzyl-2-((5-(thiophenyl) furan-2-yl) methylene) hydrazine-1-thioformamide is small in toxic and side effect, and nerve cell damage can be protected or improved by targeting SLC11A2; and a new choice is provided for treating or improving nerve cell injury.

The invention discloses a continuous flow production method of high-purity chlorantraniliprole, and belongs to the technical field of chemical synthesis. The method comprises the following steps: simultaneously pumping a mixed solution containing 3-bromo-1-(3-chloro-2-pyridyl)-1H-pyrazole-5-formic acid, a solvent, an acid-binding agent and 2-amino-5-chloro-N, 3-dimethylbenzamide and a catalyst solution into a mixing unit of a continuous flow reactor I to form a reaction mixture flow; the material flow enters a continuous flow reactor I for condensation reaction to obtain a chlorantraniliprole solution; simultaneously pumping the mixed solution and a quenching agent solution into a continuous flow reactor II, and quenching to separate out crystals; and continuously centrifugally separating the quenching liquid containing the crystals, washing and drying to obtain a chlorantraniliprole refined product. According to the present invention, the full continuous flow process is adopted, the reaction unit and the post-treatment unit are included, the material continuously flows, and when the process is stable, the material composition, the temperature and other parameters in the reactor are only related to the reaction position and do not change with time, such that the production process and the product quality stability are ensured.

There is provided a process for preparing 5,7-dimethyl-N-((1R,4R)-4- (pentyloxy)cyclohexyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide, said process comprising at least a step of amide coupling a 5,7-Dimethylpyrazolo[1,5-a]pyrimidine-3-carboxylic acid with trans-4-(pentyloxy)cyclohexanamine using carbonyldiimidazole (CDI).

The invention relates to the technical field of liquid crystal polymers, and discloses a high-temperature-resistant, electricity-conducting and heat-conducting graphene-LCP material and a preparation method thereof.The preparation method comprises the steps that a diacid monomer, p-hydroxybenzoic acid and 4, 4 '-bis (4-hydroxyphthalimide)-benzamido benzene are subjected to a carboxyl reaction, liquid crystal polyarylester is obtained and mixed with graphene oxide, and the high-temperature-resistant, electricity-conducting and heat-conducting graphene-LCP material is obtained. The liquid crystal polyarylester molecular chain contains an imide ring, so that the thermal decomposition mass loss temperature of the liquid crystal polyarylester LCP material can be improved. The liquid crystal polyarylester contains amido bonds and forms strong interaction with hydroxyl and carboxyl on the surface of the graphene oxide, the interfacial compatibility between the graphene oxide and the liquid crystal polyarylester can be improved, the graphene oxide does not need surface modification and has good dispersity in the LCP material, a conductive path is formed, and the conductivity and the antistatic performance are improved.

The invention provides a preparation method of an insecticide synergistic responsive release delivery system, and belongs to the technical field of insecticides. Chlorantraniliprole insecticide is dissolved in an acetone solvent containing Tween 80 to form a drug-carrier complex; then polymerizing the N-isopropylacrylamide temperature-sensitive monomer under the action of an ammonium persulfate and tetramethylethylenediamine initiation system to form a temperature-responsive hydrogel matrix; four key parameters including the optimal molar ratio, the optimal embedding temperature, the optimal embedding time and the optimal phase change temperature control precision of an amido hydrophilic group and an isopropyl hydrophobic group are calculated by applying a double-layer game model, and a drug-carrier complex is embedded into a hydrogel matrix through a physical embedding effect to construct a three-layer nested delivery structure; the technical problem that the pesticide effect utilization rate is low due to the fact that the pesticide lacks an accurate temperature-responsive release control mechanism in environmental application is solved.

The invention relates to the technical field of organic synthesis, in particular to a preparation method of N, N '-dichloro-1, 4-benzenedicarboxamide, which comprises the following steps: taking terephthalamide as an initial raw material and tert-butyl hypochlorite as a chlorination reagent; the method comprises the following steps: carrying out a chlorination reaction on terephthalamide and tert-butyl hypochlorite in a solvent under the protection of inert gas by controlling the reaction temperature, and after the reaction is finished, carrying out post-treatment to obtain N, N-dichloro-1, 4-phthalimide. The preparation method of the N, N '-dichloro-1, 4-benzenedicarboxamide comprises the following steps: taking terephthalamide and tert-butyl hypochlorite as raw materials, and carrying out one-step reaction to generate a dichloro product. Compared with a traditional N, N '-dichloro-1, 4-benzenedicarboxamide production method, the preparation method has the advantages that the amount of three wastes generated is small, the product yield is high, the product purity is high, the operation is safe and convenient, and the preparation method is more suitable for industrial application.

The invention discloses a dual-emission carbon dot nano-enzyme, a preparation method thereof and application of the dual-emission carbon dot nano-enzyme in enhancing photosynthesis and salt stress resistance of crops, and relates to the field of nano-material technologies and agricultural engineering.The dual-emission carbon dot nano-enzyme is prepared by taking glutathione and formamide as precursors through ultrasonic treatment, microwave heating, purification and drying; the double-emission carbon dots have emission in blue light and red light ranges, are well overlapped with chloroplast absorption, and can be used as a light converter to promote photosynthesis of crops, improve the utilization rate of solar energy and enhance photosynthesis of crops; in addition, the compound has excellent SOD-like activity, and can improve germination of crop seeds and growth of seedlings under salt stress.

The invention relates to the technical field of preparation of N-(2, 4-dinitrophenyl)-4-nitrobenzoyl aniline, in particular to a method for preparing a nitro amide compound by adopting a microreactor. The method for preparing the nitro amide compound comprises the following steps: introducing a sulfuric acid solution of 4-nitro-N-phenylbenzamide and a nitric acid aqueous solution into a microreactor, and reacting to obtain N-(2, 4-dinitrophenyl)-4-nitrobenzamide; the microreactor is provided with at least two reaction modules which are connected in series, and a sulfuric acid solution of 4-nitro-N-phenylbenzamide is divided into at least two strands which are respectively fed into a first reaction module of the microreactor and other reaction modules except the first reaction module; and the nitric acid aqueous solution enters the microreactor in a way of at least one stream. According to the method, the microreactor is used as a reaction carrier, the temperature in the reaction process is controllable, the raw material conversion rate is increased, and the residual amount of an intermediate N-4-nitro-(4-nitrophenyl) benzamide is reduced.

The invention provides a preparation method of a (S)-5-(2, 2-dimethyl tetrahydro-2H-pyran-4-yl)-N-methyl-N-phenyl-1H-indole-2-formamide compound, which comprises the following steps: by taking a compound 1 as an initial raw material, reacting the compound 1 with a boric acid ester reagent to obtain a boric acid ester compound 2; the method comprises the following steps: by taking a compound 3 as an initial raw material, reducing carbonyl through enzyme catalysis to obtain a compound 4, then protecting alcoholic hydroxyl through a sulfonylation reagent to obtain a compound 5, and finally, directly coupling the compound 5 with a compound 2 under the action of a catalyst to obtain a target product compound 6. The whole process is low in experimental condition requirement, simple to operate, high in yield and suitable for process amplification.

The invention relates to a composite aerogel for water treatment and a preparation method thereof, and the preparation method comprises the following steps: activating graphene oxide, and then carrying out amidation reaction on the activated graphene oxide, aminated beta-cyclodextrin and hexamethylenediamine to obtain modified graphene; then carrying out hydrothermal reaction on the GO / BiOCOOH composite material, a Bi < 3 + > solution and formamide to obtain a modified GO / BiOCOOH composite material; crosslinking in a lignin aqueous solution to obtain hydrogel; and finally, performing supercritical drying to obtain the composite aerogel. The preparation method has the beneficial effects that by constructing macroscopic blocky aerogel, the problems that a powder material is easy to lose and difficult to recycle are effectively solved; the high photocatalytic activity is still kept under the condition that iodine doping is not used, and the possibility of secondary pollution of free iodine to a water body due to instability of the material is reduced; under the synergistic effect of the aerogel and the photocatalytic reaction, the efficient proceeding of the adsorption and desorption-photocatalytic reaction is realized; the material is high in stability, easy to recover, capable of being recycled through simple desorption, high in cycle index and long in service life.

Improved process for the preparation of 4-amino-N-[(1S)-1-(4- chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4- piperidinecarboxamide and its salts. The present invention relates to an improved process for the preparation of 4-amino-N- [(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4- piperidinecarboxamide, which is referred to as Capivasertib and represented by the following structural formulae, Formula-1 The present invention also relates to a solid state forms of Capivasertib of formula-1 and process for its preparation.

The present invention relates to pharmaceutical compositions containing N-(1,3-dimethylpyrazol-4-yl)sulfonyl-6-[3-(3,3, 3-trifluoro-2,2-dimethyl-propoxy)pyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide, a solid dispersion of (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-7V-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-en indol-5-yl)cyclopropanecarboxamide, and a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-quinoline-3-carboxamide, including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical compositions.

This document relates to crystalline or amorphous forms of oxoisoindole-5-carboxamide compounds, or salts or solvates thereof. It also discloses compositions containing the crystalline or amorphous forms, as well as methods for preparing and using the crystalline or amorphous forms. The resulting crystalline or amorphous forms have excellent solid-state stability and are of great value in drug development, formulation development, and production.

The invention relates to the technical field of fine chemical engineering, in particular to a method and a system for continuously preparing p-phenylenediamine, the method for preparing p-phenylenediamine comprises the following steps: in an organic solvent, in the presence of a composite nickel-based molecular sieve catalyst, carrying out chlorination reaction on terephthalamide and chlorine, and after the reaction is finished, filtering, washing and drying to obtain p-phenylenediamine. Separating the composite nickel-based molecular sieve catalyst to obtain a reaction solution containing N, N '-dichloro terephthalamide; the composite nickel-based molecular sieve catalyst comprises an active component NiO, a carrier SiO2, a carrier Al2O3, an auxiliary agent Fe2O3 and a metal alkaline substance, the method comprises the following steps: carrying out rearrangement reaction on a reaction solution containing N, N '-dichloro-terephthalamide and an alkali solution, and after the reaction is finished, carrying out post-treatment to obtain p-phenylenediamine. The method has the remarkable advantages of high reaction efficiency, high product purity, low energy consumption, intrinsic safety and environmental friendliness, and a new process is provided for production of p-phenylenediamine.

The invention discloses a pyrazolecarboxamide compound and application of the pyrazolecarboxamide compound. Specifically, the invention discloses a compound shown as a formula I or a pharmaceutically acceptable salt thereof. The compounds of the present invention are IL-17 small molecule modulators, and can be used for the treatment or prevention of IL-17 mediated diseases, such as autoimmune diseases.

The invention relates to the field of organic chemical synthesis, in particular to a quinazolinone compound synthesized by carbon dioxide and a preparation method of the quinazolinone compound. According to the preparation method for synthesizing the quinazolinone compound from carbon dioxide, carbon dioxide, a 2-aminobenzamide compound and aryl halide are taken as raw materials, and are subjected to a heating reaction in the presence of a palladium metal catalyst, a ligand, a reducing agent, alkali and an organic solvent to generate the quinazolinone compound. The mechanism is as follows: carbon dioxide forms an intermediate A under the conditions of alkali and a reducing agent, aryl halide and the intermediate A form a carbonyl metal compound B under the action of a palladium metal catalyst, and then the carbonyl metal compound B reacts with a 2-aminobenzamide compound under the action of the alkali and the reducing agent to obtain the quinazolinone compound. The catalyst system has universality to various types of 2-aminobenzamide and derivatives and aryl halides thereof, the raw materials are wide in source, cheap and easy to obtain, and the reaction process is simple and controllable.

The invention relates to the field of complex bone defect treatment, and discloses a nano material with an efficient antibacterial effect and a preparation method thereof.The preparation method comprises the steps that ammonium bismuth citrate and luteolin are mixed and dissolved in formamide, the mixture is put into a reaction kettle to react, a reaction solution is obtained, and Bi-Lu CDs in formamide is obtained after centrifugation and filtration; mixing the MSN-coated Bi-Lu CDs with amino-modified mesoporous silica microspheres, centrifuging, dispersing in deionized water, and drying in vacuum to obtain pure MSN-coated Bi-Lu CDs powder; the preparation method comprises the following steps: preparing a polyurethane dispersion liquid from polyurethane, spraying the polyurethane dispersion liquid on a quartz plate to form a polyurethane film, and spraying MSN and Bi-Lu CDs powder on the polyurethane film to carry out metal spraying treatment; a second precipitate is obtained; drying in vacuum to obtain J-Bi-LuCDs M (at) Au powder; the problems that in the prior art, due to the fact that a pure carbon dot material lacks active diffusion power, the treatment effect on complex tissue defects and bacterial biofilms is still limited, and a precursor material is poor in biocompatibility, not prone to dissolution and low in bioavailability are solved.

The invention belongs to the technical field of perovskite materials, and particularly relates to application of triazole formamide, a perovskite precursor solution and a preparation method and application of the perovskite precursor solution, triazole formamide serves as an additive to be added into perovskite, and triazole formamide is 1, 2, 4 triazole-3-formamide. According to the method, the homogenization of the large-area film is realized and the defects in the perovskite polycrystalline film are effectively passivated in the nucleation and crystallization process in the process of preparing the large-area perovskite polycrystalline film by using the small-molecule triazole formamide as the multi-active-site additive regulation and control solution method; therefore, the photoelectric conversion efficiency and the stability of the perovskite photovoltaic miniature module are improved.

The invention discloses a polypropylene beta crystal form compound nucleating agent, a beta crystal form homo-polypropylene pipe special material and a production process thereof, and belongs to the technical field of polypropylene materials. The polypropylene beta crystal form compound nucleating agent disclosed by the invention is prepared from the following components in percentage by weight: 15 to 20 percent of beta crystal form nucleating agent, 60 to 70 percent of antioxidant, 7 to 11 percent of calcium stearate and 5 to 10 percent of polyphthalamide. The polypropylene beta crystal form compound nucleating agent has the advantages of high beta crystal form conversion rate, high rigidity, low dosage, good dispersity and the like, and the normal and low temperature impact strength of the material can be greatly improved. The beta crystal form homo-polypropylene pipe special material product obtained by the production process has excellent impact strength, thermal deformation temperature and flexural modulus performance, also has excellent processability, and is suitable for the fields of chemical pressure pipelines and pipe fittings, extrusion and compression molded plates, filter plates and solid rods.

The invention relates to the technical field of fabric spinning, and discloses a lightweight warm-keeping polyester wadding material and a preparation method thereof. The preparation method comprises the following steps: firstly, reacting 3, 5-dihydroxybenzamide with dicarboxyl polyethylene glycol to prepare polyethylene glycol amide polyester containing acylamino and polyethylene glycol chain segments; modifying cellulose aerogel by using the polyester, and finally blending the modified aerogel and PET (Polyethylene Terephthalate) to obtain the target polyester wadding. In the polyester, an amido bond and a hydroxyl group on the surface of the cellulose aerogel can form a hydrogen bond and partial covalent crosslinking, and an ether bond is similar to a PET ester group structure, so that the dispersity and compatibility of the modified aerogel in PET can be improved, and the flexibility of the PET can also be enhanced. The cellulose aerogel is porous, loose and small in heat conductivity coefficient, air convection can be limited, a heat conduction path is prolonged, heat loss is reduced, and finally the requirements for light weight and heat preservation of the polyester wadding are met.

The invention discloses a preparation method, an intermediate and application of menochromone. The preparation method comprises the following steps: reacting 4-bromopyrrole-2-carboxylic acid with propargylamine to generate 4-bromo-N-propynyl pyrrole-2-formamide; the preparation method comprises the following steps: reacting 4-bromo-N-propinyl pyrrole-2-formamide with pinacol borane to generate a mixture; reacting the mixture with 2-(t-butyloxycarboryl amino)-5-iodo-1H-imidazole to generate (E)-(5-(3-(4-bromo-1H-pyrrole-2-formamido) prop-1-ene-1-yl)-1H-imidazole-2-yl) tert-butyl carbamate, and reacting the (E)-(5-(3-(4-bromo-1H-pyrrole-2-formamido) prop-1-ene-1-yl)-1H-imidazole-2-yl) tert-butyl carbamate with the tert-butyl carbamate; and reacting the (E)-(5-(3-(4-bromo-1H-pyrrole-2-formamido) prop-1-ene-1-yl)-1H-imidazole-2-yl) tert-butyl carbamate with a dioxane hydrochloride solution, so as to generate the menochromone. The invention provides a preparation method of menosin, which is short in synthetic route, simple and convenient to operate, high in product yield and suitable for industrial production.

The present invention relates to fungicidal compositions comprising as component 1) the compound (I) methyl (2Z)-3-methoxy-2-[(4-methylbiphenyl-3-yl)oxy]prop-2-enoate) and as active component 2) the compound (II) N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]benzamide wherein the weight ratio of compound (I) to compound (II) is from 10:1 to 1:10.

The application discloses a benzothiophenone derivative, a preparation method and application thereof. The benzothiophenone derivative, a tautomer, an optical isomer, a hydrate, a solvate, a pharmaceutically acceptable salt or a prodrug thereof, and the chemical structure of the benzothiophenone derivative is shown as formula (I), wherein R is any one of the following groups: a substituted alkane and N-benzyl-2-chloroformamide. The benzothiophenone derivative can regulate a PPARγ target as an anti-type 2 diabetes drug, can reserve insulin sensitivity, can avoid related side effects caused by a PPARγ full agonist, and has a 'highly efficient and safe' hypoglycemic effect.